These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Temocillin in the treatment of serious gram-negative infections. Lindsay G; Beattie AD; Taylor EW Drugs; 1985; 29 Suppl 5():191-3. PubMed ID: 3896739 [TBL] [Abstract][Full Text] [Related]
4. Temocillin concentrations in human tissues. Gould JG; Meikle G; Cooper DL; Horton R Drugs; 1985; 29 Suppl 5():167-70. PubMed ID: 3928320 [TBL] [Abstract][Full Text] [Related]
5. Use of temocillin in typhoid fever, hepatobiliary disease and other infections. Tanphaichitra D; Kanjanapanjapol S; Srimuang S; Robinson OP Drugs; 1985; 29 Suppl 5():201-5. PubMed ID: 3928321 [TBL] [Abstract][Full Text] [Related]
6. Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration. Laterre PF; Wittebole X; Van de Velde S; Muller AE; Mouton JW; Carryn S; Tulkens PM; Dugernier T J Antimicrob Chemother; 2015 Mar; 70(3):891-8. PubMed ID: 25433006 [TBL] [Abstract][Full Text] [Related]
7. Temocillin treatment of serious infections due to gram-negative bacilli in an intensive care unit. Offenstadt G; Lesage D; Hericord P; Pinta P; Leaute JB; Amstutz P Drugs; 1985; 29 Suppl 5():213-20. PubMed ID: 3896741 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic results and tissue concentrations of temocillin in surgical patients. Wittke RR; Adam D; Klein HE Drugs; 1985; 29 Suppl 5():221-6. PubMed ID: 4029028 [TBL] [Abstract][Full Text] [Related]
9. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients. Vandecasteele SJ; Miranda Bastos AC; Capron A; Spinewine A; Tulkens PM; Van Bambeke F Int J Antimicrob Agents; 2015 Dec; 46(6):660-5. PubMed ID: 26603304 [TBL] [Abstract][Full Text] [Related]
11. [Temocillin and urinary tract infections]. Vallée M; Bruyère F; Roblot F; Brureau L Prog Urol; 2017 Oct; 27(12):609-617. PubMed ID: 28869169 [TBL] [Abstract][Full Text] [Related]
12. Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects. Maudgal DP; Lanzini A; Northfield TC; Bridges C; Joseph AE Drugs; 1985; 29 Suppl 5():146-50. PubMed ID: 4029019 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of temocillin in volunteers. Hampel B; Feike M; Koeppe P; Lode H Drugs; 1985; 29 Suppl 5():99-102. PubMed ID: 4029032 [TBL] [Abstract][Full Text] [Related]
14. Temocillin penetration of peripheral lymph. Bergan T; Olszewski WL; Engeset A Drugs; 1985; 29 Suppl 5():114-7. PubMed ID: 4029013 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of temocillin after intravenous and intramuscular administration. Modr Z; Morávek J; Dvorácek K; Sechser T; Janků I; Krebs V Czech Med; 1986; 9(4):181-6. PubMed ID: 3102181 [TBL] [Abstract][Full Text] [Related]
16. Potential role of temocillin in the treatment of biliary sepsis. Uwaydah M; Vartivarian S; Harakeh H; Awdeh A; Najjar F Drugs; 1985; 29 Suppl 5():186-90. PubMed ID: 4029024 [TBL] [Abstract][Full Text] [Related]
17. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis]. Grenier B; Gilly R Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602 [TBL] [Abstract][Full Text] [Related]
18. Temocillin treatment of gynaecological infections with special reference to blood and tissue concentrations. Weissenbacher ER; Gutschow K; Bauernfeind A; Luehr HG Drugs; 1985; 29 Suppl 5():178-81. PubMed ID: 3896737 [TBL] [Abstract][Full Text] [Related]